ESPE Abstracts (2015) 84 P-2-275

Do Pancreatic Functions Predict Cardiac and Liver Iron Loading in Transfusion-Dependent [beta]-Thalassemia Major Patients Using Cardiovascular and Liver T2-Star (T2*)Magnetic Resonance?

Galila Mokhtar, Wafaa Ibrahim, Nancy Elbarbary, Randa Matter, Ahmed Ibrahim & Safa Sayed


Ain Shams University, Cairo, Egypt


Background: Regular and frequent red blood cell transfusions have significantly increased the life expectancy of patients with β-thalassemia major (β-TM). However, when no appropriate chelation therapy is available, patients accumulate iron in the heart, liver, spleen, pancreas, and endocrine glands, leading to progressive organ dysfunction.

Objective and hypotheses: To assess the correlation between cardiac and hepatic T2*MRI findings with the endocrine and exocrine pancreatic functions in known β-TM patients.

Method: A total of 44 children and adolescents β-TM patients and 44 healthy controls were investigated via: serum amylase, lipase, triglyceride index, oral glucose tolerance test, and T2* MRI to assess iron content in the heart and liver.

Results: Overt diabetes was found in 9.4% and 45.5% of patients had impaired fasting glucose. Median cardiac T2* was 22 ms (12–31 ms) and LIC was 6 ms (4–9 ms). Cardiac T2* was less than 10 ms in 21.4% indicating heavy load with iron in cardiac tissues. There is a significant decrease in serum amylase (87.5 vs 63.5 IU/l, P=0.003) and lipase (94 vs70 IU/l, P=0.056) among enrolled patients in comparison to control group. Thalassemic diabetic showed low serum amylase (32.5 vs 59.5, P=0.0005), serum lipase (39.5 vs 68, P=0.0007), low cardiac T2* was found (7 vs 22 ms, P=0.0006) and low LIC (2 vs 6 ms, P=0.0006) than other β-TM patients without diabetes. Inverse correlation was found between triglyceride index with cardiac T2* (r=−0.376, P=0.014) and low LIC (r=−0.376, P=0.014 respectively) but not with serum lipase (r=−0.099, P=0.533), (r=−0.222, P=0.1570) and serum amylase (r=−0.191, P=0.225), (r=−0.053, P=0.738) respectively.

Conclusion: Follow up of thalassemic patients with impaired fasting glucose together with intensive chelation therapy may help to prevent the development of cardiac and hepatic siderosis.

Article tools

My recent searches

No recent searches.